Clinical Trials Directory

Trials / Completed

CompletedNCT01533129

The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism

Phase 4 Study That Evaluates the Effects of Two Different Testosterone Replacement Regiments on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Subjects With Hypogonadotrophic Hypogonadism.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Gulhane School of Medicine · Academic / Other
Sex
Male
Age
18 Years – 26 Years
Healthy volunteers
Not accepted

Summary

The study searched for answers to two questions 1. What is the effect of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance? 2. Regarding the above parameters, is there any difference between daily transdermal testosterone implementation and intramuscular injection performed in three weeks.

Conditions

Interventions

TypeNameDescription
DRUGTestogel 50 mg transdermal gel50mg testosterone gel implementation on every night
DRUGTestosterone 250mg injectionThe testosterone 250mg ester IM injections performed in three weeks.

Timeline

Start date
2008-08-01
Primary completion
2011-04-01
First posted
2012-02-15
Last updated
2020-07-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01533129. Inclusion in this directory is not an endorsement.

The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonad (NCT01533129) · Clinical Trials Directory